A Boston-based biopharmaceutical company is revolutionizing the weight-loss drug industry. Syntis Bio has created a daily oral treatment called SYNT-101 that mimics the results of gastric bypass ...

A new daily weight-loss pill could be just as effective as the popular injectables that help patients lower their blood sugar and lose unwanted weight. "I think we're really at the beginning of a ...

The pill, poised to revolutionize the weight loss world, may be up for FDA approval in late 2025. A daily pill to rival Ozempic is one step closer to hitting the market. Pharmaceutical giant Eli ...

The move: Eli Lilly stock soared 12% on Thursday to $823.80. Why: The gains came after Eli Lilly announced positive phase 3 trial data for Orforglipron, the pill form of its GLP-1 weight loss drug.

Participants on the highest dose of the pill lost an average of 16 pounds, or nearly 8% of their body weight. This level of weight loss is consistent with the amount shed over the same period ...

Pfizer announced on Monday that it is halting development of its oral weight-loss pill after one patient experienced liver issues. The company said it halted development of danuglipron ...

But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days before, rival pharma giant Pfizer had announced it was abandoning its ...

That medication has been available by prescription since 2019 for the treatment of Type 2 diabetes but is not FDA-approved for weight loss. GLP-1 pills can be a promising option for people with ...

Now, a new contender is stepping into the spotlight. It’s called Orforglipron, and it’s a daily weight loss pill that could be a game-changer in how we manage both weight and blood sugar.

the weight-loss drugs are expected to join the mission along with lifestyle changes. Eli Lilly's (LLY.N) new experimental pill has seen success in its Phase 3 clinical trial. The new pill ...

Lilly said weight loss hadn’t plateaued at the time the study ended, suggesting that patients might lose more weight. The pill lowered blood sugar levels by an average of 1.3%. Ozempic lowered ...